MARKET

NBIX

NBIX

Neurocrine Biosciences Inc
NASDAQ
95.69
+0.54
+0.57%
Closed 16:24 03/23 EDT
OPEN
95.78
PREV CLOSE
95.15
HIGH
96.44
LOW
94.86
VOLUME
391.20K
TURNOVER
0
52 WEEK HIGH
129.29
52 WEEK LOW
75.25
MARKET CAP
9.24B
P/E (TTM)
62.08
1D
5D
1M
3M
1Y
5Y
Citigroup Sticks to Its Buy Rating for Neurocrine (NBIX)
TipRanks · 2d ago
Teva ends enrollment in late-stage Austedo cerebral palsy trial
Seeking Alpha · 03/13 16:59
Neurocrine Biosciences Announced Results from the Real-World RE-KINECT™ Study Published in the Journal of Patient-Reported Outcomes Demonstrating the Effects of Possible Tardive Dyskinesia (TD) on Patient Health and Social Functioning
Benzinga · 03/09 21:33
BRIEF-Neurocrine Biosciences Presents Data On In Vitro Dissolution Performance Of Ingrezza® (Valbenazine) Capsule Contents Via Soft Foods Or Feeding Tube At Amda - Paltc 2023 Annual Conference
Reuters · 03/09 13:33
Karuna initiated Neutral at Cantor citing lead candidate KarXT
Seeking Alpha · 03/08 13:46
‘2023 Rally Was a Bull Trap,’ Says Morgan Stanley. But These Stocks Still Have Upside
NASDAQ · 03/06 00:06
‘2023 Rally Was a Bull Trap,’ Say Morgan Stanley. But These Stocks Still Have Upside
TipRanks · 03/06 00:06
Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines
Seeking Alpha · 03/04 18:45
More
About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering and developing pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis and uterine fibroids. Its product pipeline includes INGREZZA (valbenazine), which provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 milligrams (mg), 60 mg and 80 mg capsules); ONGENTYS (opicapone) is an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease; ORILISSA (elagolix) is used for the management of moderate to severe endometriosis pain in women. Its pipeline also includes DYSVAL (valbenazine), ORIAHNN (elagolix, estradiol, and norethindrone acetate and elagolix capsules), ALKINDI/ALKINDI SPRINKLE (hydrocortisone), and EFMODY (hydrocortisone modified-release hard capsules).

Webull offers kinds of Neurocrine Biosciences, Inc. stock information, including NASDAQ:NBIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NBIX stock methods without spending real money on the virtual paper trading platform.